Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Palivizumab (Synagis)

Also known as Synagis

Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed palivizumab to treat congenital heart defect, interstitial lung disease, rabies, and blastomycosis.

Ajax-loader Loading...